cobioer/科佰生物 品牌
代理商厂商性质
南京市所在地
FLT3 p.G583_Y599dup Reference Standard
面议PIK3CA p.G1049R Reference Standard
面议AI-Edigene® ESR1 p.Y537S Reference Standard P
面议PIK3CA p.E545D Reference Standard
面议CYP2D6*10 Reference Standard
面议CYP2D6*10 Reference Standard
面议GJB2 p.M34T Reference Standard
面议GJB2 p.G4D Reference Standard
面议GJB2 p.G12Vfs*2/p.M34T double mutation Reference S
面议GJB2 p.G12Vfs*2 Reference Standard
面议AI-Edigene® FGFR2(E17)- BICC1(E3) Translocati
面议AI-Edigene® c-KIT p.V560Del Reference Standar
面议| CBP80001-5 | |||||||||||||||||||||||||||||||||||
| I. Background | |||||||||||||||||||||||||||||||||||
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
计算数据下载：DC198N0154.tmb | |||||||||||||||||||||||||||||||||||
